The Health Care Portfolio, Series 21 ("Trust") seeks to maximize total return through capital appreciation with a secondary objective of current income.
|Wrap Fee Price||$8.859300|
|Remaining Deferred Sales Charge||$0.245000|
|Mandatory Maturity Date||7/27/2018|
|NASDAQ Ticker Symbol||CHCRUX|
|Inception Unit Price||$10.000000|
|Inception Bid Price||$9.900000|
|Inception Liquidation Price||$9.655000|
|Deferred Sales Charge Dates||
|Number of Holdings||40|
|Historical Annual Dividend Distribution||$0.089500|
All data is subject to change daily. Data may differ from the prospectus due to different data sources or market changes. Please refer to prospectus for additional information about the trust including the portfolio section criteria. Source: FactSet Research Systems Inc. unless otherwise noted. The total percentages may not be equal to 100% due to rounding. N/A indicates that certain securities have not been identified and/or classified by the data provider. A unit is a combination of securities or types of securities traded together.
|Weighted Average Price/Earnings (P/E) Ratio||27.35|
|Weighted Average Price/Book (P/B) Ratio||8.06|
|Weighted Average Market Cap (MM)||$69,969.08|
|US Common Stock||96.65%|
|Non US Common Stock||3.35%|
|Health Care Equipment & Supplies||20.61%|
|Health Care Providers & Services||15.24%|
|Health Care Technology||2.24%|
|Life Sciences Tools & Services||7.13%|
|Food & Staples Retailing||3.06%|
Past performance is no guarantee of future results. Investment returns and principal value will fluctuate with changes in market conditions. Investors' units, when redeemed, may be worth more or less than their original cost.
Principal Investment Strategy
Under normal circumstances, the Trust invests at least 80% of the value of its assets in stocks of companies that are classified as being in the health care sector by the Global Industry Classification Standard (“GICS”), or are believed by the Sponsor to have a significant level of revenues directly derived from health care related products and services. The Sponsor selects securities for the portfolio that it believes have the potential to achieve the Trust’s investment objective.
The Sponsor selects U.S.-traded securities that it believes are core holdings of a health care portfolio. To select the portfolio, the Sponsor follows a disciplined process that includes both quantitative and qualitative analysis. The Sponsor begins with the securities of companies that are classified as being in the health care sector by GICS, or are believed by the Sponsor to have a significant level of revenues directly derived from health care related products and services, and are either components of the Russell 3000 Index (“R3K”) or have market capitalizations larger than the smallest company within the R3K. The Sponsor then reduces the size of this universe by performing quantitative screening, which may be primarily based on, but not limited to, the following factors:
The Sponsor then reduces the securities by performing qualitative analysis, which may be primarily based on, but not limited to, the following factors:
Risks and Other Considerations
As with all investments, you may lose some or all of your investment in the Trust. No assurance can be given that the Trust’s investment objective will be achieved. The Trust also might not perform as well as you expect. This can happen for reasons such as these:
See “Investment Risks” in Part A of the prospectus and “Risk Factors” in Part B of the prospectus for additional information.
Please see the Trust prospectus for more complete risk information.
Unit Investment Trusts are fixed, not actively managed and should be considered as part of a long-term strategy. Investors should consider their ability to invest in successive portfolios, if available, at the applicable sales charge. UITs are subject to annual fund operating expenses in addition to the sales charge. Investors should consult an attorney or tax advisor regarding tax consequences associated with an investment from one series to the next, if available, and with the purchase or sale of units. Guggenheim Funds Distributors, LLC does not offer tax advice.
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Guggenheim Investments represents the investment management business of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investments Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisors to the referenced funds.
© 2017 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The information provided does not constitute a solicitation of an offer to buy, or an offer to sell securities in any jurisdiction, or to any person to who, it is not lawful to make such an offer. All content has been provided for informational purposes only. It is not intended to be and should not be construed as, (i) a recommendation; (ii) legal or tax advice; and/or (iii) a legal opinion. Always consult a financial, tax and /or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.